Introduction
Status epilepticus (SE) comprises a range of disparate conditions, often categorised into convulsive and nonconvulsive SE. Generalised convulsive or tonic-clonic SE is easily recognised and the severity well established. The numerous other forms of SE are diverse with variable semiology and are thus more difficult to classify and study. Controversies regarding the term ''convulsive'' is one contributing reason. 1 Some authors define ''convulsive'' as widespread tonic-clonic activity generalised to the entire body, alternatively hemi-side, as opposed to minor motor activity during a focal seizure. 2 Motor features are frequent in complex focal seizures (CFS), [3] [4] [5] including complex focal SE (CFSE), 6 listed as a subgroup of CFS in the ILAE classification of 1981. 7 The Epilepsy
Research Foundation workshop report from 2005 includes focal seizures with motor elements, e.g. epilepsia partialis continua, in NCSE group. 8 Others define focal seizures with any motor elements as focal convulsive. 9, 10 NCSE is commonly classified as generalised or focal. Generalised NCSE consists of absence, atypical absence and de novo late onset absence. 11 Some authors include myoclonic SE. 8 Focal NCSE can be divided into simple and complex focal SE. 8, 11 Subtle SE is sometimes included in NCSE, 9, 12, 13 but as it represents a late or end stage of generalised convulsive SE (GCSE), it is commonly considered separately. 2, 14 NCSE is often characterised by prolonged behavioural and cognitive changes as observed in CFS or absence seizures. Patients may experience subjective, vegetative symptoms or aphasia, etc., as seen in simple focal seizures (SFS). NCSE can occur as persistent unconsciousness with only EEG verification of ongoing epileptic activity, but it is difficult to avoid over-diagnosing NCSE if diagnosis is based mainly on EEG.
By its very nature, NCSE is often overlooked by clinicians, and hence both incidence and true outcome are more uncertain than for GCSE. Limited access to EEG contributes to diagnostic inaccuracy. 16 In European studies, the annual incidence rates of NCSE range from 2.6 to 7.8 per 100,000, depending on the definition of ''convulsive''. [16] [17] [18] Lasting sequelae caused by NCSE is considered rare and also difficult to differentiate from the cause of the seizure and complications in the clinical course. 11, 19, 20 Prognosis seems to be highly dependent on the underlying cause. 21 Studies using standardised tests for neurological and neuropsychological sequelae are scarce. Occurrence of less prominent neuropsychological sequelae is not established. The objective of this study was to examine the semiology, aetiology, treatment and outcome in our unselected patient cohort of NCSE. Much emphasis has been put on the presence or absence of focal motor elements. There is little evidence that this is important for the prognosis. We included NCSE satisfying the conservative definition of ''non-convulsive'', excluding all motor elements, as well as seizures with limited motor features. STESS (Status Epilepticus Severity Score) 13 was evaluated as a predictor of outcome.
Materials and methods

Study design
This is a retrospective study of 39 patients with 48 episodes of NCSE treated consecutively following the established routine at our adult neurological department (!16 years). The department serves as the primary unit for 441,646 inhabitants (per 2003) of Hordaland County. There are no competing neurological departments in the county. The patient population is thus unselected. Status episodes were identified from a clinical database including all patients with an ICD-10 diagnosis of SE. We reviewed the files of all patients admitted 2004-2009, except for those registered with the code G41.0 (generalised tonic-clonic status epilepticus). The ICD-10 codes included were G41.1, G41.2, G41.8 and G41.9. The diagnoses were set at time of care by the treating neurologist. Aetiology of epilepsy, conditions triggering NCSE, duration of seizures, semiology, EEG findings, treatment and outcome measures were recorded. The aetiology of epilepsy was distinguished from the triggers of individual NCSE.
Definition, classification and duration of NCSE
NCSE was defined as epileptic seizures lasting more than 30 min and without major motor symptoms and/or convulsions. Convulsions were defined as widespread tonic-clonic activity generalised to the entire body or entire hemi-side. Hence, we included focal seizures with motor activity in NCSE. Motor symptoms, defined by simple or complex focal seizures and myoclonic seizures, were included. The length of SE was registered as 30-35 min, 35-60 min, 1-2 h, 2 h-1 day, 1 day-1 week, >1 week, respectively.
Seizures were classified as ''established epilepsy'' or ''no prior epilepsy''. NCSEs with prior epileptic seizures that occurred solely during the present acute situation and within a week before were classified as ''no prior epilepsy''.
Exclusion criteria
Episodes initiated by a primary or secondary generalised tonicclonic seizure (GTC) were excluded, hence also subtle SE. Similarly, NCSE episodes with a GTC within 24 h before onset of NCSE were excluded. Moreover, NCSE following anoxic brain damage was excluded. We did not exclude patients without ictal EEG confirmation, as this would have led to a further selection bias.
Outcome measures
Outcome was separated into five groups: death, severe sequelae, moderate sequelae, mild sequelae, and full restitution. Neurological, cognitive, and somatic sequelae were considered for all categories. The classification of sequelae was based on clinical evaluation by a neurologist. Severe sequelae were defined as permanent conditions of major significance for daily living (e.g. paresis in a body part, significantly impaired memory or cognitive function, or other somatic disorders (see below)). Moderate sequelae were defined as either severe conditions lasting more than one month, but not being permanent, or permanent conditions with mild or moderate significance for daily living. Mild sequelae implied slight transient conditions or serious conditions lasting less than one month, but no permanent adverse outcome. 22 The sequelae were attributed to the NCSE, to the underlying aetiology and/or trigger, or to secondary consequences of these. Examples of consequences were deep venous thrombosis, pneumonia, and myocardial infarction.
One patient had two NCSEs two days apart, and these were combined for evaluation of sequelae. Minimum observation time was two years after the index NCSE.
STESS (Status Epilepticus Severity Score) was applied retrospectively. 13 STESS is a prognostic score based on four outcome predictors: age (<65 years = 0, !65 years = 1), history of previous seizures (yes = 0, no = 1), worst seizure type (simple focal, complex focal, absence, and myoclonic seizures = 0, generalised convulsive = 1, NCSE in coma/subtle SE = 2), and extent of consciousness impairment (alert or somnolent/confused = 0, stuporous or comatose = 1) as determined before start of treatment. We used a cut off of !3 and calculated the negative predictive value (NPV) for not dying or suffering severe sequelae in the group with a negative test (i.e. value < 3). Two-sided Fischer's exact test was used to analyse the dichotomous categorical variables, i.e. ''severe sequelae (including fatal outcome)/non-severe sequelae'' vs STESS !/< 3, ''fatal outcome/ not fatal outcome'' vs STESS !/< 3 and ''severe sequelae (including fatal outcome)/non-severe sequelae'' vs ''established epilepsy/no prior epilepsy''. In patients with more than one NCSE, only the first NCSE was included in these analyses to avoid dependency between variables.
All the patients were contacted in writing a minimum of two years after the NCSE to investigate their current function. Those capable of completing simple questionnaires were presented with the 5-item (5 level) EuroQol survey (EQ-5D) and the 10-item Quality of Life in Epilepsy survey (QOLIE-10). [23] [24] [25] 3. Results
Patient characteristics
Forty-eight NCSE episodes in 39 patients were examined: 22 men and 17 women. Two men had three episodes each; two women and three men had two episodes each. Mean age was 63 years, range 18-96 years.
Of the 39 patients, 25 (64%) had suffered epileptic seizures before their index NCSE; however, for two of them (two patients, three seizures) this had happened only two days prior to the NCSE. Hence 23/39 (59%) of the patients (contributing to 31/48 of the NCSEs) qualified for a diagnosis of established epilepsy. Of the 16 patients (41%) with de novo seizures, seven had acute symptomatic seizures and the remaining had remote underlying aetiology, but suffered the NCSE as their first epileptic seizure. The causes of epilepsy/epileptic seizures are listed in Table 1 , with cerebrovascular disease being the most frequent.
Twenty-one of the 23 patients with established epilepsy used antiepileptic drugs (AED) at index NCSE. The remaining two patients had used AED previously.
NCSE triggers
Infections were the most frequent trigger, provoking or contributing to 12 of the 41 NCSEs (29%) in patients with remote aetiology (Table 1) .
NCSE classification
Most NCSEs (37/48(77%)) were CFSEs. Nine were SFSE, including two episodes of epilepsia partialis continua. There was one episode of myoclonus SE and one episode of atypical absence SE.
Most seizures included some motor elements in addition to automatisms and stereotypic complex movements: 15/48 had clonic jerks in one extremity, 11/48 had clonic jerks in one extremity and in the face, 3/48 had clonic jerks in one extremity (arm) and adversive head movement, 4/48 had intermittent and alternating clonic jerks in one side of the body, 2/48 had clonic jerks in the face only, 2/48 had myoclonic jerks, 1/48 had cycling and waving movements, and 1/48 had adversive head movement only. Clonic and myoclonic jerks could not always be differentiated as they were based on clinical observations. Duration of NCSE varied greatly. Four episodes lasted < 60 min, six episodes 1-2 h, 17 episodes 2 h-1 day, 15 episodes 1-7 days, and six episodes continued for more than one week.
EEG recordings
EEG recordings prior to the index NCSE (n = 23/39) had shown epileptic activity in 13 patients, possible epileptic activity in six patients, and no epileptic activity in four patients. Sixteen of the 39 patients had no previous EEG recordings, 14 of them with no history of epileptic seizures.
EEG recordings were conducted during the NCSE in 21/48 cases and confirmed the clinical diagnosis by showing ictal epileptic activity. In another 11/48 cases, EEG recordings were conducted postictally: nine showed slow postictal activity, one showed epileptic activity and one showed focal EEG dysfunction consistent with the clinical NCSE semiology. In 16/48 cases no EEG was conducted during or immediately after the NCSE. Fifteen of these were in patients with established epilepsy, the last one being a clinically convincing NCSE with ascertained effect of AED treatment. (Fig. 1) . General anaesthesia was not used for any of the NCSEs.
Treatment of NCSE
In the subgroup of NCSEs with no prior epilepsy, only 1/17 NCSE self-terminated and none terminated after one AED, 7/17 ended after two AEDs and 9/17 needed three or more AEDs. In the subgroup with established epilepsy, 3/31 NCSE episodes selfterminated, 9/31 ended after one AED, 13/31 after two AEDs and only 6/31 needed three or more AEDs.
Outcome
Three of the 39 patients died in hospital during the NCSE admission (7.7%) and 3/48 NCSE episodes lead to death (6.3%). One of these patients suffered an acute symptomatic NCSE after cerebral media infarction and died seven days after the NCSE. Another patient had established epilepsy and suffered a NCSE semiologically similar to previous seizures, but presently triggered by a small acute cerebral infarction, pneumonia and subtherapeutic AED concentration on admission. She died one day after the index NCSE. In these two patients causes of death were also triggers of the NCSEs. The third patient had no prior epilepsy, but had undergone cerebral haemorrhage one year earlier. Pneumonia developed two days after the NCSE and lead to death five days after the index seizure.
Four of 47 estimable NCSEs lead to severe sequelae (8.5%); three of them being caused by the aetiology or trigger of the NCSE. Two Table 1 Characteristics of patients (n = 39) and NCSEs (n = 48).
Patients with remote aetiology of epilepsy/epileptic seizure n = 32 patients developed hemiparesis after acute symptomatic NCSE from cortical haemorrhage and cerebral infarction, respectively. One developed cognitive impairments and personality change after NCSE during varicella encephalitis. One patient had severe sequelae indirectly caused by NCSE, as immobilisation caused deep venous thrombosis and the anticoagulation treatment prevented potentially beneficial brain surgery for acute hydrocephalus. The patient was further described as mentally reduced. Severe sequelae or death occurred after 6/16 NCSE without prior epilepsy, compared to only 1/31 with established epilepsy. Considering the first NCSE in every patient the numbers were 6/16 and 1/23, respectively (p = 0.013, Fisher's Exact Test).
Eight of 47 episodes lead to moderate sequelae; seven caused by the NCSE and one by the condition triggering the NCSE. Three of the eight gave somatic sequelae due to myocardial infarction in connection with the seizures. Five of the eight gave neurological/ cognitive sequelae: three lead to confusion and impairment of daily living; one caused unsteady gait, nystagmus, cognitive slowing and hallucinations; and one caused paresis in a leg and restricted field of vision. Three of 47 episodes gave mild sequelae, where one was caused by the NCSE and two caused by the triggering condition. All three were transient neurological and/or cognitive sequelae lasting less than one month. In 29/47 there were no sequelae at all.
Cognitive sequelae across categories of severity were described after 7/47 NCSE (14.9%). In three of them it could not be decided if this was caused by the underlying aetiology or the NCSE itself. In the remaining cases, new cognitive difficulties could have been explained by an added AED. In most medical records cognitive changes were not addressed specifically.
At follow-up a minimum of two years after the NCSE, 18/39 patients had died. Two of twenty-one were living abroad and hence lost to follow-up. Eight of nineteen patients were in nursing homes due to old age or mental retardation. Only 11/19 were able to complete questionnaires. Of these patients 8/11 had suffered NCSEs classified as leading to no sequelae, 2/11 to moderate sequelae, and 1/11 to severe sequela. The mean score for general quality of life in the QOLIE-10 was 2.38 AE 0.92 (range 1 (very good)-5 (very bad)). The mean value for the Health VAS in the EQ-5D-5L was 54.30 AE 22.73 (range 0-100, where 100 is best possible health).
Status Epilepticus Severity Score (STESS)
A favourable low STESS (0-2) was highly predictive of a good outcome. Comparing STESS to the outcome variable severe sequelae (including fatal outcome)/non-severe sequelae, the NPV (Negative Predictive Value) was 96% (26/27) (p < 0.002, Fisher's Exact Test). This means that only 1/27 NCSEs was falsely predicted by STESS as leading to non-severe sequelae.
Discussion
NCSE is a condition with potential for severe sequelae. In our patients, the absence of previous seizures was associated with poorer treatment response and worse outcome than in patients with known epilepsy. Underlying aetiologies and triggers were the determinants for mortality and severe sequelae. Our population with NCSE is unselected, covering all patients in a well-defined geographical cohort. The minimum observation time of two years is a further strength in assessing the impact of sequelae.
Stroke was the most prevalent cause of epilepsy, and infection was the most common triggering factor of individual NCSEs. A prospective study of all types of SE from 2001 found stroke to be the aetiology in 50% of the cases. 17 Knowledge of the relative contribution of different aetiologies for NCSE is scarce. 12, 26, 27 This is surprising and probably due to variations of the definition of NCSE, as well as the heterogeneity of underlying conditions and lack of accessible reports. Moreover, few studies differentiate between the underlying aetiology of epilepsy and the triggers of individual NCSEs. This distinction is important for optimal treatment. In a small study from 1996, NCSEs not preceded by generalised tonic-clonic seizures had low serum AED and influence of drugs and toxins as the most frequent triggers. 28 Semiologically, the most common form of NCSE in our patients was CFSE (77%), corroborating a German epidemiologic study. 17 NCSE in patients without previous epilepsy was more difficult to terminate than NCSE in those with established epilepsy. SFSE and CFSE have been reported to be more treatment resistant as de novo seizures in patients with acute CNS disorders, compared to SE in patients with established epilepsy. 15, 29 We have found a similar trend for refractory convulsive SE. 22 Three of 48 NCSE episodes lead to death (6.3%). A study of 100 NCSE cases, excluding subtle SE, found a higher mortality rate of 18%. 30 Another more recent study compared NCSE proper to comatose NCSE. 31 Corresponding to the seizure forms in our study, the mortality rate was 6% and similar to our findings. Severe sequelae and death were most often caused by the underlying disease, as previously reported. 11, [19] [20] [21] However, we found that less severe sequelae more often seemed to be explained by the NCSE itself. NCSE outcome was worst in de novo seizures, corroborating other studies. 30 Favourably low STESS, calculated retrospectively, was strongly related to a good outcome. This applied even though GCSE and subtle SE were not included, and illustrates that STESS is a valuable tool in predicting outcome of NCSE.
Cognitive sequelae after NCSE were rarely listed in the medical records, and when addressed causality was uncertain. Existence of cognitive sequelae after NCSE in adults has been questioned. Animal models have indicated that CFSE can cause such sequelae, 32, 33 but clinical studies are scarce and show contradictory results. 10, [34] [35] [36] [37] Long-time follow-up after more than two years is important to assess the outcome for this patient group. However, many patients had died or were unable to respond, illustrating NCSE as a marker of ill health. Perceived health was low also in the reporting group, contrasting the relatively mild sequelae registered. Mean health VAS was 54.3, compared to 61.6 found in a study of patients awaiting epilepsy surgery. 38 This could reflect that some sequelae, like cognitive impairment, have remained undetected; however, underlying diseases leading to the NCSEs is an alternative explanation for this. Identification of the direct effect of NCSE on outcome vs the effect of underlying causes is limited by the retrospective design. The heterogeneity of both aetiology and trigger factors complicates this further. Cognitive sequelae are incompletely assessed without formal neuropsychological testing. Some authors require EEG confirmation for the NCSE diagnosis. [39] [40] [41] EEG confirmation is important in comatose patients, but less so in seizures with a clinical semiology. Moreover, at present there are no firmly established EEG criteria for NCSE. 41, 42 Since EEG is not available 24/ 7 at our hospital, a restriction to such criteria would lead to important selection bias regarding both treatment and prognosis. NCSEs without EEG confirmation were therefore included.
Conclusions
NCSE can be fatal or lead to severe sequelae. Underlying aetiologies and triggers are important for outcome. De novo NCSEs are more difficult to treat and are associated with worse outcome than NCSEs in patients with established epilepsy. Acute mortality in our material is comparatively low, indicating effective treatment. STESS is valuable in predicting outcome. Cognitive sequelae can be overlooked and need attention. We found few episodes leading to cognitive sequelae, but prospective studies with systematic measures are needed and ongoing.
